Sign Up Today and Learn More About HistoSonics Stock
Invest in or calculate the value of your shares in HistoSonics or other pre-IPO companies through EquityZen's platform.
HistoSonics Stock
Developing a non-invasive, autonomous robotic platform capable of destroying tissue at a sub-cellular level
About HistoSonics Stock
Founded
2009
Headquarters
Ann Arbor, MI, US
Total Funding
86.1M
Industries
Software, Data and Analytics, Artificial Intelligence
HistoSonics, Inc. was created to advance the development of histotripsy, a science discovered and developed by leading scientists at the University of Michigan to provide improved therapies for patients. According to the company, its exclusive license to intellectual property, significant financial support, and strategic partnerships have helped HistoSonics develop Robotically Assisted Sonic Therapy (RAST)™, a novel beam therapy capable of destroying tissue at a sub-cellular level. HistoSonics’ team of specialists and industry leaders is based in Ann Arbor, Michigan.
HistoSonics Press Mentions
Stay in the know about the latest news on HistoSonics
HistoSonics® Publishes Results of its Pivotal #HOPE4LIVER Trials
businesswire • Sep 03, 2024
The Week’s 10 Biggest Funding Rounds: Cybersecurity Leads With Kiteworks’ Nearly Half-Billion-Dollar Deal
news • Aug 16, 2024
HistoSonics Raises $102M in Series D Financing
finsmes • Aug 16, 2024
HistoSonics Announces Oversubscribed $102 Million Series D Financing to Scale Launch of Non-Invasive Histotripsy Platform
vcaonline • Aug 15, 2024
HistoSonics Pockets $102M in Oversubscribed Series D
mpo-mag • Aug 15, 2024
HistoSonics Management
Leadership team at HistoSonics
VP of Regulatory & Clinical Affairs
Michael Daniel
CFO
Jon Freeman
Join now and verify your accreditation status to gain access to:
- HistoSonics current valuation
- HistoSonics stock price
- Available deals in HistoSonics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in HistoSonics stock?
Accredited investors can buy pre-IPO stock in companies like HistoSonics through EquityZen funds. These investments are made available by existing HistoSonics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell HistoSonics stock?
Shareholders can sell their HistoSonics stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
